Ahn Hye Shin, Kim Dong Wook, Lee Yoo Jin, Lee Chang Yoon, Kim Ji-Hoon, Choi Yoon Jung, Lee Song, Ryoo Inseon, Huh Jung Yin, Sung Jin Yong, Kwak Jin Young, Baek Hye Jin
Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea.
Department of Radiology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Front Endocrinol (Lausanne). 2018 Mar 15;9:102. doi: 10.3389/fendo.2018.00102. eCollection 2018.
For detecting tumor recurrence of medullary thyroid carcinoma (MTC) in the neck, an appropriate frequency and interval of postoperative ultrasonography (US) surveillance remains unclear. This study aimed to assess an appropriate interval and frequency of postoperative neck US surveillance for detecting tumor recurrence in patients who had undergone thyroid surgery due to MTC.
A total of 86 patients who had undergone thyroid surgery for the treatment of MTC and had at least one postoperative US follow-up examination at any of nine affiliated hospitals were included. Postoperative follow-up US, clinical, and histopathological results of patients were reviewed. The tumor recurrence/persistence rate of MTC was investigated, and the interval and session number of postoperative follow-up US and clinicopathologic factors were compared between tumor recurrence/persistence and non-recurrence groups.
Of the 86 patients, 22 (25.6%) showed tumor recurrence/persistence. Of the 22 patients with tumor recurrence/persistence, 11 (50%) showed structural recurrence/persistence in the neck on follow-up US. In these 11 patients, the mean interval and session number of postoperative follow-up US between initial surgery and the first US detection of recurrence/persistence was 41.3 ± 39.3 months (range, 6-128 months) and 2.6 ± 2.3 (range, 1-8), respectively. On follow-up US, 6 (54.5%, 6/11) were diagnosed with tumor recurrence/persistence within 3 years of the initial surgery. Tumor recurrence/persistence was significantly correlated with TNM stage ( < 0.001) and multiplicity/bilaterality ( = 0.013).
For detecting MTC recurrence/persistence, postoperative US surveillance at 1-year intervals may be sufficient within the first 3 years after thyroid surgery, but depending on the presence of relevant risk factors, annual or biannual US surveillance may be recommendable for 4-10 years after thyroid surgery.
对于检测甲状腺髓样癌(MTC)颈部肿瘤复发而言,术后超声(US)监测的合适频率和间隔仍不明确。本研究旨在评估因MTC接受甲状腺手术患者术后颈部US监测以检测肿瘤复发的合适间隔和频率。
纳入86例因MTC接受甲状腺手术且在9家附属医院中的任何一家至少接受过1次术后US随访检查的患者。回顾患者的术后随访US、临床及组织病理学结果。调查MTC的肿瘤复发/持续率,并比较肿瘤复发/持续组与未复发组之间术后随访US的间隔和次数以及临床病理因素。
86例患者中,22例(25.6%)出现肿瘤复发/持续。在这22例肿瘤复发/持续的患者中,11例(50%)在随访US中显示颈部结构复发/持续。在这11例患者中,初次手术至首次US检测到复发/持续之间术后随访US的平均间隔和次数分别为41.3±39.3个月(范围6 - 128个月)和2.6±2.3次(范围1 - 8次)。在随访US中,6例(54.5%,6/11)在初次手术后3年内被诊断为肿瘤复发/持续。肿瘤复发/持续与TNM分期(<0.001)和多灶性/双侧性(=0.013)显著相关。
为检测MTC复发/持续,甲状腺手术后的前3年内,每年进行1次术后US监测可能就足够了,但根据相关危险因素的存在情况,甲状腺手术后4 - 10年推荐每年或每半年进行1次US监测。